HomeInsightsPE

Epigral Ltd P/E Ratio

Epigral Ltd P/E Ratio

download
stocks purchased

₹ 0.8 Cr

Volume transacted

stocks purchased

5.2 K

stocks traded

Last Updated time: 22 Jul 9.00 AM

Image

Epigral Ltd

NSE: EPIGRAL

PE

31.2

Last updated : 22 Jul 9.00 AM

Key Highlights

    The P/E Ratio of Epigral Ltd is 31.2 as of 22 Jul 9.00 AM .a1#The P/E Ratio of Epigral Ltd changed from 16 on March 2021 to 23.3 on March 2024 . This represents a CAGR of 13.35% over 3 years. a1#The Latest Trading Price of Epigral Ltd is ₹ 1469 as of 22 Jul 15:30 .a1#The PE Ratio of Chemicals Industry has changed from 18.4 to 26.3 in 5 years. This represents a CAGR of 7.41%a1# The PE Ratio of Automobile industry is 18.5. The PE Ratio of Chemicals industry is 55.3. The PE Ratio of Finance industry is 23.8. The PE Ratio of IT - Software industry is 29.3. The PE Ratio of Retail industry is 143.1. The PE Ratio of Textiles industry is 20.4. In 2024a1#The Market Cap of Epigral Ltd changed from ₹ 4045 crore on March 2021 to ₹ 4553 crore on March 2024 . This represents a CAGR of 4.02% over 3 years. a1#The Revenue of Epigral Ltd changed from ₹ 534.88 crore to ₹ 526.77 crore over 8 quarters. This represents a CAGR of -0.76% a1#The EBITDA of Epigral Ltd changed from ₹ 189.49 crore to ₹ 157.52 crore over 8 quarters. This represents a CAGR of -8.83% a1#The Net Pr of Epigral Ltd changed from ₹ 107.79 crore to ₹ 77.28 crore over 8 quarters. This represents a CAGR of -15.33% a1#The Dividend Payout of Epigral Ltd changed from 5.88 % on March 2019 to 10.61 % on March 2024 . This represents a CAGR of 34.33% over 2 years. a1#

Open Demat Account

Lead form image

Enter your mobile no. to continue

+91

*By signing up you agree to our terms & conditions

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

×

Historical P/E Ratio of Epigral Ltd

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

Historical P/E Ratio of Epigral Ltd

Period
Mar '210
Mar '2216
Mar '2311.1
Mar '2423.3

Company Fundamentals for Epigral Ltd

Market Cap

6,106 Cr

EPS

47.2

P/E Ratio (TTM) *

31.2

P/B Ratio (TTM) *

4.9

Day’s High

1479.3

Day’s Low

1388.85

DTE *

0.8

ROE *

15.6

52 Week High

1582.1

52 Week Low

870.0

ROCE *

16.4

* All values are consolidated

Last Updated time: 22 Jul 9.00 AM

* All values are consolidated

Last Updated time: 22 Jul 9.00 AM

Image

Epigral Ltd

NSE: EPIGRAL

PRICE

1469.55

55.05 (3.89%)

stock direction

Last updated : 22 Jul 15:30

×

PRICE

The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.

Share price Over Time

1M

1Y

3Y

5Y

* All values are in Rupees

SWOT Analysis Of Epigral Ltd

Strength

6

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

Asset Value vs Market Value of Epigral Ltd

Market Value

6,106

Asset Value

502

11.2 X

Value addition

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Epigral Ltd316,106
Pidilite Industries Ltd89160,161
SRF Ltd5270,190
Linde India Ltd16069,076
Deepak Nitrite Ltd5338,881
Gujarat Fluorochemicals Ltd8235,684

Key Valuation Metric of Epigral Ltd

Earnings

195 Cr

31.2 X

PE Ratio

Market Cap

₹6106Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

Earnings

195 Cr

31.2 X

PE Ratio

Market Cap

₹6106Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Chemicals Industry over time

PE Ratio of Top Sectors

×

Historical Market Cap of Epigral Ltd

Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore

Historical Market Cap of Epigral Ltd

Period
Mar '210
Mar '224046
Mar '233919
Mar '244554

* All values are a in crore

×

Historical Revenue of Epigral Ltd

Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.

Historical Revenue of Epigral Ltd

Period
Jun '22535
Sep '22557
Dec '22538
Mar '23567
Jun '23456
Sep '23479
Dec '23474
Mar '24527

* All values are a in crore

×

Historical EBITDA of Epigral Ltd

PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.

Historical EBITDA of Epigral Ltd

Period
Jun '22189
Sep '22182
Dec '22166
Mar '23159
Jun '2397
Sep '23109
Dec '23125
Mar '24158

* All values are a in crore

×

Historical Net Profit of Epigral Ltd

Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue

Historical Net Profit of Epigral Ltd

Period
Jun '22108
Sep '2292
Dec '2277
Mar '2377
Jun '2332
Sep '2338
Dec '2349
Mar '2477

* All values are a in crore

×

Historical Dividend Payout of Epigral Ltd

Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.

Historical Dividend Payout of Epigral Ltd

Period
Mar '190
Mar '200
Mar '210
Mar '220
Mar '236
Mar '2411

* All values are a in %

About Epigral Ltd

About Epigral Ltd

    Meghmani Finechem Limited was incorporated in 2007 as a subsidiary of Meghmani organics ltd, under the provisions of Companies Act, 1956. The Company at present is primarily engaged in manufacturing and selling of Chlor Alkali & its Derivatives. The Company is also engaged in Trading of Agrochemical products. The Hon'ble National Company Law Tribunal ('NCLT') Ahmedabad Bench vide its order dated 3 May 2021 (the 'Order'), has approved the Scheme of Arrangement ('the Scheme') to demerge the Agrochemicals and Pigments Division of Meghmani Organics Limited ('MOL') along with its investment in Optionally Convertible Redeemable Preference Shares ('OCRPS') of Meghmani Finechem Limited ('MFL') and transferred to the Company as a going concern. The certified true copy of the Order issued by NCLT Ahmedabad Bench on 05th May, 2021 filed with The Ministry of Corporate Affairs (the 'MCA') Registrar of Companies ('ROC') Gujarat, Dadra, Nagar and Haveli on 10th May, 2021. The Scheme is effective from 10th May, 2021. By this Meghmani Finechem Limited was demerged from Meghmani Organics in FY 2020-21 to empower the Company grow its Chlor-Alkali business. The demerged Company is now being driven by the second generation of the promoter family that came on the Board of the Company in 2016. The Company's Chlor-Alkali business was commissioned in 2009, growing from an installed capacity of 1,88,000 TPA in 2015 to 3,15,000 TPA at the close of FY 2020-21. The Company is now among the leading players in India's chlor alkali industry. The Company grew its business following the commissioning of new plants (Caustic Soda, Hydrogen Peroxide and the 36 MW Captive Power Plant). The timely commissioning of the plants represented the faith of the management in the long-term potential of the sector and country. The Caustic Soda capacity was expanded by 1,27,000 TPA to 2,94,000 TPA and commissioned in June 2020. The Captive Power Plant capacity was increased by 36 MW to 96 MW, commissioned in June 2020. The Company commissioned a 60,000 TPA Hydrogen Peroxide plant in July 2020. The complement of these manufacturing capacities will broadbase the Company's manufacturing foundation, strengthen integration, moderate the cost structure and provide a platform for value-addition. The payback from these investments is likely to be recovered in 4-5 years, validating the Company's commitment to profitable growth. During the year under review 2020-21, the Company announced the implementation of a manufacturing facility for Epichlorohydrin (ECH) and Chlorinated Polyvinyl Chloride (CPVC) which are expected to add attractively to the Company's volumes and profitability across the future. The ECH project will be the first time that the product will be manufactured in India. The 50,000 TPA facility will be based on glycerin feedstock that is obtained from 100% renewable resources, addressing the need for cost-effectiveness and moderated carbon footprint. The project is likely to be commissioned during the first quarter of the next financial year. The CPVC Resin project of 30,000 TPA at a cost of H190 Cr is likely to be commissioned in the second quarter of FY 2022-23.

Epigral Ltd News Hub

News

Epigral announces board meeting date

Epigral will hold a meeting of the Board of Directors of the Company on 24 July 2024. Powe...

Read more

16 Jul 202417:34

News

Epigral commissions CPVC Compound manufacturing plant at Dahej

Epigral has successfully commissioned 35,000 TPA capacity of Chlorinated Polyvinyl Chlorid...

Read more

29 Jun 202410:30

News

Epigral to conduct AGM

Epigral announced that the 17th Annual General Meeting (AGM) of the company will be held o...

Read more

13 Jun 202417:40

News

Board of Epigral recommends final dividend

Epigral announced that the Board of Directors of the Company at its meeting held on 22 Apr...

Read more

22 Apr 202415:08

News

Epigral jumps after Q4 PAT rises 57% QoQ to Rs 77 cr

Profit before tax jumped 53.47% QoQ to Rs 113.46 crore in Q4 FY24. EBITDA stood at Rs 155 ...

Read more

22 Apr 202415:34

News

Epigral to hold board meeting

Epigral will hold a meeting of the Board of Directors of the Company on 22 April 2024. Pow...

Read more

09 Apr 202417:39

Product Composition by Percentage (Revenue)

FAQs for PE of Epigral Ltd

What is Epigral Ltd current share price?

The current market price of Epigral Ltd as of July 22, 2024 is ₹1469.55.

What is Epigral Ltd's market cap?

Epigral Ltd's market capitalisation stood at ₹6,106 Cr as of July 22, 2024

What are Epigral Ltd's total net assets?

According to Epigral Ltd's most recent financial filings, the company's net assets total ₹501.9 Cr.

Is Epigral Ltd making a profit or loss?

Epigral Ltd's net Profit as of July 22, 2024 is close to ₹195 Cr.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199